| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.915 | Aldehyde oxidase inhibitor | 0.915 0.003 CID_14116 | CID_14116 | |
| 0.779 | 0.014 | 0.802 | Caspase 9 stimulant | 0.802 0.011 CID_14116 | CID_14116 | |
| 0.711 | 0.003 | 0.711 | GABA C receptor rho-3 antagonist | 0.706 0.003 CID_14116 | ||
| 0.693 | 0.003 | 0.718 | Peroxidase inhibitor | 0.718 0.003 CID_14116 | CID_14116 | |
| 0.601 | 0.014 | 0.638 | 5 Hydroxytryptamine release stimulant | 0.638 0.011 CID_14116 | CID_14116 | |
| 0.598 | 0.049 | 0.626 | Apoptosis agonist | 0.626 0.044 CID_14116 | CID_14116 | |
| 0.555 | 0.015 | 0.574 | Histamine release inhibitor | 0.574 0.013 CID_14116 | CID_14116 | |
| 0.543 | 0.003 | 0.618 | Cystathionine beta-synthase inhibitor | 0.618 0.003 CID_14116 | CID_14116 | |
| 0.546 | 0.02 | 0.557 | 5 Hydroxytryptamine release inhibitor | 0.557 0.018 CID_14116 | CID_14116 | |
| 0.524 | 0.017 | 0.555 | Caspase 3 stimulant | 0.555 0.014 CID_14116 | CID_14116 | |
| 0.52 | 0.014 | 0.573 | Free radical scavenger | 0.573 0.01 CID_14116 | CID_14116 | |
| 0.512 | 0.013 | 0.554 | Amyloid beta aggregation inhibitor | 0.554 0.01 CID_14116 | CID_14116 | |
| 0.513 | 0.019 | 0.57 | Antioxidant | 0.57 0.013 CID_14116 | CID_14116 | |
| 0.501 | 0.013 | 0.514 | Superoxide dismutase inhibitor | 0.514 0.012 CID_14116 | CID_14116 | |
| 0.517 | 0.03 | 0.517 | Cholesterol antagonist | 0.505 0.032 CID_14116 | ||
| 0.49 | 0.004 | 0.49 | Alcohol oxidase inhibitor | 0.457 0.004 CID_14116 | ||
| 0.486 | 0.004 | 0.486 | Tyrosine 3 hydroxylase inhibitor | 0.477 0.004 CID_14116 | ||
| 0.472 | 0.005 | 0.472 | 5 Hydroxytryptamine uptake stimulant | 0.444 0.008 CID_14116 | ||
| 0.469 | 0.002 | 0.518 | Creatine kinase inhibitor | 0.518 0.002 CID_14116 | CID_14116 | |
| 0.492 | 0.031 | 0.501 | Calcium channel L-type activator | 0.501 0.028 CID_14116 | CID_14116 | |
| 0.497 | 0.035 | 0.497 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.45 0.061 CID_14116 | ||
| 0.475 | 0.023 | 0.475 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.456 0.026 CID_14116 | ||
| 0.448 | 0.007 | 0.448 | Alpha-N-acetylglucosaminidase inhibitor | 0.361 0.011 CID_14116 | ||
| 0.475 | 0.046 | 0.515 | 15-Lipoxygenase inhibitor | 0.515 0.037 CID_14116 | CID_14116 | |
| 0.455 | 0.028 | 0.481 | 12-Lipoxygenase inhibitor | 0.481 0.023 CID_14116 | CID_14116 | |
| 0.411 | 0.007 | 0.42 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.42 0.007 CID_14116 | CID_14116 | |
| 0.408 | 0.005 | 0.408 | 5-Lipoxygenase inhibitor | 0.403 0.005 CID_14116 | ||
| 0.432 | 0.03 | 0.467 | Lipoxygenase inhibitor | 0.467 0.024 CID_14116 | CID_14116 | |
| 0.438 | 0.038 | 0.438 | Streptokinase A inhibitor | 0.389 0.05 CID_14116 | ||
| 0.437 | 0.039 | 0.437 | MAP kinase kinase 6 inhibitor | 0.378 0.072 CID_14116 | ||
| 0.415 | 0.018 | 0.443 | Pyruvate kinase inhibitor | 0.443 0.015 CID_14116 | CID_14116 | |
| 0.397 | 0.004 | 0.397 | Porphobilinogen synthase inhibitor | 0.284 0.006 CID_14116 | ||
| 0.408 | 0.017 | 0.408 | RNA-directed DNA polymerase inhibitor | 0.398 0.018 CID_14116 | ||
| 0.397 | 0.01 | 0.452 | Topoisomerase II inhibitor | 0.452 0.008 CID_14116 | CID_14116 | |
| 0.392 | 0.005 | 0.392 | GABA C receptor agonist | 0.307 0.009 CID_14116 | ||
| 0.39 | 0.004 | 0.558 | Estrogen receptor beta antagonist | 0.558 0.003 CID_14116 | CID_14116 | |
| 0.412 | 0.027 | 0.44 | Hypoxia-inducible factor 1 alpha inhibitor | 0.44 0.022 CID_14116 | CID_14116 | |
| 0.385 | 0.006 | 0.427 | Aldehyde dehydrogenase inhibitor | 0.427 0.005 CID_14116 | CID_14116 | |
| 0.379 | 0.004 | 0.4 | GABA C receptor rho-2 antagonist | 0.4 0.003 CID_14116 | CID_14116 | |
| 0.375 | 0.007 | 0.41 | Neurotrophic factor enhancer | 0.41 0.005 CID_14116 | CID_14116 | |
| 0.425 | 0.058 | 0.463 | Transcription factor NF kappa B inhibitor | 0.463 0.05 CID_14116 | CID_14116 | |
| 0.4 | 0.037 | 0.407 | Aryl hydrocarbon receptor agonist | 0.407 0.036 CID_14116 | CID_14116 | |
| 0.366 | 0.005 | 0.55 | Estrogen antagonist | 0.55 0.004 CID_14116 | CID_14116 | |
| 0.384 | 0.022 | 0.393 | Sodium/bile acid cotransporter inhibitor | 0.393 0.019 CID_14116 | CID_14116 | |
| 0.386 | 0.03 | 0.386 | Calcium channel activator | 0.371 0.037 CID_14116 | ||
| 0.364 | 0.015 | 0.408 | Melanin inhibitor | 0.408 0.011 CID_14116 | CID_14116 | |
| 0.373 | 0.026 | 0.373 | Transcription factor STAT inhibitor | 0.363 0.03 CID_14116 | ||
| 0.347 | 0.005 | 0.347 | Succinate dehydrogenase inhibitor | 0.326 0.007 CID_14116 | ||
| 0.375 | 0.034 | 0.397 | DNA damaging | 0.397 0.029 CID_14116 | CID_14116 | |
| 0.451 | 0.11 | 0.467 | Antiinflammatory | 0.467 0.102 CID_14116 | CID_14116 | |
| 0.36 | 0.019 | 0.36 | Dual specificity phosphatase inhibitor | 0.304 0.028 CID_14116 | ||
| 0.351 | 0.015 | 0.351 | Mcl-1 antagonist | 0.326 0.019 CID_14116 | ||
| 0.392 | 0.058 | 0.392 | Vasodilator, peripheral | 0.377 0.063 CID_14116 | ||
| 0.333 | 0.004 | 0.333 | Phenylalanine 4-hydroxylase inhibitor | 0.297 0.004 CID_14116 | ||
| 0.333 | 0.005 | 0.356 | Histidine decarboxylase inhibitor | 0.356 0.005 CID_14116 | CID_14116 | |
| 0.356 | 0.031 | 0.356 | Transcription factor STAT3 inhibitor | 0.336 0.038 CID_14116 | ||
| 0.333 | 0.009 | 0.356 | M18 aspartyl aminopeptidase inhibitor | 0.356 0.007 CID_14116 | CID_14116 | |
| 0.325 | 0.004 | 0.325 | GABA C receptor antagonist | 0.305 0.004 CID_14116 | ||
| 0.328 | 0.009 | 0.328 | Chelator | 0.292 0.012 CID_14116 | ||
| 0.325 | 0.008 | 0.326 | Hexokinase inhibitor | 0.326 0.008 CID_14116 | CID_14116 | |
| 0.395 | 0.079 | 0.395 | Antibacterial | 0.388 0.083 CID_14116 | ||
| 0.329 | 0.015 | 0.366 | Amylase inhibitor | 0.366 0.012 CID_14116 | CID_14116 | |
| 0.342 | 0.028 | 0.365 | Cyclic AMP phosphodiesterase inhibitor | 0.365 0.022 CID_14116 | CID_14116 | |
| 0.322 | 0.009 | 0.322 | UDP-glucose 4-epimerase inhibitor | 0.25 0.013 CID_14116 | ||
| 0.326 | 0.014 | 0.379 | NOS3 expression enhancer | 0.379 0.009 CID_14116 | CID_14116 | |
| 0.317 | 0.006 | 0.356 | Topoisomerase II alpha inhibitor | 0.356 0.005 CID_14116 | CID_14116 | |
| 0.342 | 0.032 | 0.342 | DNA synthesis inhibitor | 0.326 0.036 CID_14116 | ||
| 0.314 | 0.012 | 0.318 | Heat shock protein 90 alpha antagonist | 0.318 0.012 CID_14116 | CID_14116 | |
| 0.31 | 0.009 | 0.324 | Nitric-oxide synthase stimulant | 0.324 0.007 CID_14116 | CID_14116 | |
| 0.334 | 0.034 | 0.334 | Interleukin agonist | 0.312 0.042 CID_14116 | ||
| 0.3 | 0.005 | 0.343 | Carbonic anhydrase III inhibitor | 0.343 0.005 CID_14116 | CID_14116 | |
| 0.297 | 0.005 | 0.297 | Mannose-6-phosphate isomerase inhibitor | 0.264 0.009 CID_14116 | ||
| 0.308 | 0.018 | 0.336 | Lipid peroxidase inhibitor | 0.336 0.014 CID_14116 | CID_14116 | |
| 0.293 | 0.008 | 0.309 | Carbonic anhydrase XV inhibitor | 0.309 0.007 CID_14116 | CID_14116 | |
| 0.296 | 0.013 | 0.326 | NADPH oxidase inhibitor | 0.326 0.009 CID_14116 | CID_14116 | |
| 0.292 | 0.011 | 0.306 | Heat shock protein 90 antagonist | 0.306 0.009 CID_14116 | CID_14116 | |
| 0.31 | 0.031 | 0.31 | Anesthetic general | 0.282 0.038 CID_14116 | ||
| 0.323 | 0.046 | 0.323 | Insulysin inhibitor | 0.323 0.046 CID_14116 | ||
| 0.282 | 0.005 | 0.282 | Potassium channel (Ca-activated) activator | 0.242 0.009 CID_14116 | ||
| 0.294 | 0.018 | 0.34 | Monophenol monooxygenase inhibitor | 0.34 0.014 CID_14116 | CID_14116 | |
| 0.337 | 0.062 | 0.337 | Vasodilator, coronary | 0.328 0.067 CID_14116 | ||
| 0.337 | 0.062 | 0.343 | Apoptosis antagonist | 0.343 0.059 CID_14116 | CID_14116 | |
| 0.277 | 0.004 | 0.277 | HIV-1 integrase (Overall Integration) inhibitor | 0.246 0.005 CID_14116 | ||
| 0.317 | 0.045 | 0.38 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.38 0.029 CID_14116 | CID_14116 | |
| 0.276 | 0.005 | 0.296 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.296 0.004 CID_14116 | CID_14116 | |
| 0.275 | 0.004 | 0.275 | GABA C receptor rho-1 antagonist | 0.274 0.004 CID_14116 | ||
| 0.28 | 0.01 | 0.321 | Interleukin 4 antagonist | 0.321 0.007 CID_14116 | CID_14116 | |
| 0.298 | 0.029 | 0.299 | Non-steroidal antiinflammatory agent | 0.299 0.028 CID_14116 | CID_14116 | |
| 0.273 | 0.004 | 0.303 | Alpha tubulin antagonist | 0.303 0.004 CID_14116 | CID_14116 | |
| 0.289 | 0.021 | 0.289 | Protein-tyrosine phosphatase inhibitor | 0.285 0.022 CID_14116 | ||
| 0.273 | 0.005 | 0.44 | Estrogen agonist | 0.44 0.004 CID_14116 | CID_14116 | |
| 0.315 | 0.048 | 0.332 | Hypoglycemic | 0.332 0.042 CID_14116 | CID_14116 | |
| 0.272 | 0.005 | 0.272 | CF transmembrane conductance regulator agonist | 0.261 0.005 CID_14116 | ||
| 0.285 | 0.02 | 0.291 | Phospholipase C inhibitor | 0.291 0.019 CID_14116 | CID_14116 | |
| 0.286 | 0.021 | 0.322 | Tubulin antagonist | 0.322 0.017 CID_14116 | CID_14116 | |
| 0.292 | 0.029 | 0.311 | DNA methyltransferase I inhibitor | 0.311 0.023 CID_14116 | CID_14116 | |
| 0.268 | 0.01 | 0.268 | ATPase inhibitor | 0.261 0.011 CID_14116 | ||
| 0.259 | 0.003 | 0.284 | DOPA decarboxylase inhibitor | 0.284 0.003 CID_14116 | CID_14116 | |
| 0.261 | 0.007 | 0.305 | Alcohol dehydrogenase inhibitor | 0.305 0.005 CID_14116 | CID_14116 | |
| 0.289 | 0.037 | 0.3 | 5 Hydroxytryptamine 1E antagonist | 0.3 0.029 CID_14116 | CID_14116 | |
| 0.261 | 0.012 | 0.261 | Ferrochelatase inhibitor | 0.199 0.023 CID_14116 | ||
| 0.253 | 0.005 | 0.277 | Beta tubulin antagonist | 0.277 0.005 CID_14116 | CID_14116 | |
| 0.262 | 0.015 | 0.316 | Topoisomerase I inhibitor | 0.316 0.009 CID_14116 | CID_14116 | |
| 0.335 | 0.088 | 0.335 | Prostaglandin dehydrogenase inhibitor | 0.311 0.097 CID_14116 | ||
| 0.297 | 0.052 | 0.332 | Antiamyloidogenic | 0.332 0.043 CID_14116 | CID_14116 | |
| 0.257 | 0.013 | 0.257 | 5 Hydroxytryptamine 3E antagonist | 0.245 0.018 CID_14116 | ||
| 0.278 | 0.035 | 0.298 | DNA methylase inhibitor | 0.298 0.028 CID_14116 | CID_14116 | |
| 0.264 | 0.021 | 0.264 | Histone acetyltransferase inhibitor | 0.243 0.029 CID_14116 | ||
| 0.248 | 0.01 | 0.248 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.19 0.017 CID_14116 | ||
| 0.333 | 0.095 | 0.333 | Immunosuppressant | 0.318 0.104 CID_14116 | ||
| 0.241 | 0.005 | 0.241 | Potassium channel large-conductance Ca-activated activator | 0.18 0.008 CID_14116 | ||
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | 0.25 0.079 CID_14116 | ||
| 0.242 | 0.007 | 0.242 | Triose-phosphate isomerase inhibitor | 0.187 0.012 CID_14116 | ||
| 0.261 | 0.026 | 0.284 | Interferon gamma antagonist | 0.284 0.022 CID_14116 | CID_14116 | |
| 0.288 | 0.057 | 0.352 | Dyrk kinase inhibitor | 0.352 0.036 CID_14116 | CID_14116 | |
| 0.236 | 0.007 | 0.236 | HIV-1 integrase (3'-Processing) inhibitor | 0.233 0.008 CID_14116 | ||
| 0.232 | 0.003 | 0.265 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.265 0.003 CID_14116 | CID_14116 | |
| 0.233 | 0.005 | 0.248 | Prolactin inhibitor | 0.248 0.004 CID_14116 | CID_14116 | |
| 0.358 | 0.132 | 0.393 | Alpha-glucosidase inhibitor | 0.393 0.118 CID_14116 | CID_14116 | |
| 0.297 | 0.071 | 0.315 | Spasmolytic | 0.315 0.065 CID_14116 | CID_14116 | |
| 0.237 | 0.012 | 0.254 | Toll-Like receptor 2 antagonist | 0.254 0.009 CID_14116 | CID_14116 | |
| 0.233 | 0.008 | 0.248 | 5 Hydroxytryptamine 3A agonist | 0.248 0.005 CID_14116 | CID_14116 | |
| 0.229 | 0.007 | 0.32 | Estrogen receptor alpha antagonist | 0.32 0.005 CID_14116 | CID_14116 | |
| 0.232 | 0.011 | 0.232 | Arachidonic acid antagonist | 0.231 0.011 CID_14116 | ||
| 0.242 | 0.022 | 0.29 | MAO A inhibitor | 0.29 0.016 CID_14116 | CID_14116 | |
| 0.234 | 0.015 | 0.234 | Catenin beta inhibitor | 0.229 0.016 CID_14116 | ||
| 0.257 | 0.038 | 0.257 | Dual specificity phosphatase 3 inhibitor | 0.22 0.051 CID_14116 | ||
| 0.231 | 0.014 | 0.264 | Xanthine oxidase inhibitor | 0.264 0.011 CID_14116 | CID_14116 | |
| 0.249 | 0.035 | 0.249 | Insulin sensitizer | 0.247 0.036 CID_14116 | ||
| 0.225 | 0.01 | 0.249 | Carbonic anhydrase VI inhibitor | 0.249 0.009 CID_14116 | CID_14116 | |
| 0.223 | 0.009 | 0.223 | Photosensitizer | 0.217 0.01 CID_14116 | ||
| 0.236 | 0.023 | 0.252 | Neurotensin receptor agonist | 0.252 0.021 CID_14116 | CID_14116 | |
| 0.265 | 0.053 | 0.265 | Psychostimulant | 0.255 0.057 CID_14116 | ||
| 0.261 | 0.049 | 0.301 | Nitric oxide antagonist | 0.301 0.04 CID_14116 | CID_14116 | |
| 0.239 | 0.03 | 0.273 | MAO inhibitor | 0.273 0.024 CID_14116 | CID_14116 | |
| 0.215 | 0.006 | 0.215 | Glutamate decarboxylase inhibitor | 0.206 0.006 CID_14116 | ||
| 0.27 | 0.061 | 0.282 | Angiogenesis stimulant | 0.282 0.056 CID_14116 | CID_14116 | |
| 0.23 | 0.021 | 0.238 | Cholesterol synthesis inhibitor | 0.238 0.019 CID_14116 | CID_14116 | |
| 0.297 | 0.09 | 0.297 | Antithrombotic | 0.294 0.092 CID_14116 | ||
| 0.23 | 0.025 | 0.232 | Cyclooxygenase 1 inhibitor | 0.232 0.025 CID_14116 | CID_14116 | |
| 0.214 | 0.009 | 0.214 | NADH dehydrogenase inhibitor | 0.188 0.011 CID_14116 | ||
| 0.21 | 0.009 | 0.21 | HIV-1 integrase (Strand Transfer) inhibitor | 0.197 0.01 CID_14116 | ||
| 0.232 | 0.031 | 0.25 | Protein kinase stimulant | 0.25 0.026 CID_14116 | CID_14116 | |
| 0.208 | 0.008 | 0.222 | Keratolytic | 0.222 0.007 CID_14116 | CID_14116 | |
| 0.204 | 0.004 | 0.27 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.27 0.003 CID_14116 | CID_14116 | |
| 0.22 | 0.021 | 0.226 | DNA intercalator | 0.226 0.02 CID_14116 | CID_14116 | |
| 0.209 | 0.01 | 0.21 | Adenylate cyclase stimulant | 0.21 0.01 CID_14116 | CID_14116 | |
| 0.251 | 0.053 | 0.253 | MAP kinase kinase 2 inhibitor | 0.253 0.053 CID_14116 | CID_14116 | |
| 0.201 | 0.005 | 0.348 | Estrogen receptor beta agonist | 0.348 0.004 CID_14116 | CID_14116 | |
| 0.205 | 0.01 | 0.205 | AMP-activated protein kinase stimulant | 0.201 0.011 CID_14116 | ||
| 0.195 | 0.004 | 0.195 | Ca2+-transporting ATPase inhibitor | 0.185 0.005 CID_14116 | ||
| 0.201 | 0.01 | 0.217 | TRPA1 agonist | 0.217 0.008 CID_14116 | CID_14116 | |
| 0.205 | 0.017 | 0.217 | Cyclooxygenase 3 inhibitor | 0.217 0.014 CID_14116 | CID_14116 | |
| 0.213 | 0.025 | 0.213 | Cell wall synthesis inhibitor | 0.211 0.026 CID_14116 | ||
| 0.301 | 0.114 | 0.301 | Calpain 2 inhibitor | 0.259 0.143 CID_14116 | ||
| 0.202 | 0.015 | 0.202 | Adenylate kinase inhibitor | 0.161 0.023 CID_14116 | ||
| 0.213 | 0.026 | 0.219 | Protein-tyrosine phosphatase 1B inhibitor | 0.219 0.024 CID_14116 | CID_14116 | |
| 0.191 | 0.005 | 0.191 | CDC25B inhibitor | 0.17 0.005 CID_14116 | ||
| 0.204 | 0.018 | 0.204 | Nav1.6 sodium channel blocker | 0.191 0.022 CID_14116 | ||
| 0.208 | 0.024 | 0.208 | Adenylate cyclase inhibitor | 0.206 0.024 CID_14116 | ||
| 0.188 | 0.005 | 0.256 | Estradiol 17 beta-dehydrogenase inhibitor | 0.256 0.004 CID_14116 | CID_14116 | |
| 0.19 | 0.008 | 0.19 | CDC25A inhibitor | 0.158 0.011 CID_14116 | ||
| 0.222 | 0.041 | 0.235 | Tumour necrosis factor antagonist | 0.235 0.036 CID_14116 | CID_14116 | |
| 0.183 | 0.004 | 0.192 | D-Ala-D-Ala ligase inhibitor | 0.192 0.004 CID_14116 | CID_14116 | |
| 0.243 | 0.064 | 0.294 | Interleukin antagonist | 0.294 0.049 CID_14116 | CID_14116 | |
| 0.194 | 0.014 | 0.194 | Telomerase inhibitor | 0.156 0.019 CID_14116 | ||
| 0.192 | 0.017 | 0.192 | Catalase inhibitor | 0.167 0.022 CID_14116 | ||
| 0.185 | 0.01 | 0.187 | Heat shock protein 70 antagonist | 0.187 0.009 CID_14116 | CID_14116 | |
| 0.188 | 0.014 | 0.218 | Beta glucuronidase inhibitor | 0.218 0.011 CID_14116 | CID_14116 | |
| 0.2 | 0.026 | 0.208 | Alkylator | 0.208 0.024 CID_14116 | CID_14116 | |
| 0.191 | 0.018 | 0.219 | MAP kinase kinase 4 inhibitor | 0.219 0.009 CID_14116 | CID_14116 | |
| 0.208 | 0.036 | 0.208 | Interleukin 6 antagonist | 0.197 0.043 CID_14116 | ||
| 0.203 | 0.032 | 0.203 | Alkaline phosphatase inhibitor | 0.199 0.033 CID_14116 | ||
| 0.238 | 0.067 | 0.254 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.254 0.058 CID_14116 | CID_14116 | |
| 0.217 | 0.047 | 0.219 | Amyloid beta precursor protein antagonist | 0.219 0.046 CID_14116 | CID_14116 | |
| 0.175 | 0.005 | 0.192 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.192 0.004 CID_14116 | CID_14116 | |
| 0.192 | 0.023 | 0.192 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.181 0.031 CID_14116 | ||
| 0.184 | 0.016 | 0.211 | Carbonic anhydrase XIII inhibitor | 0.211 0.013 CID_14116 | CID_14116 | |
| 0.181 | 0.013 | 0.181 | DNA repair enzyme inhibitor | 0.173 0.016 CID_14116 | ||
| 0.181 | 0.014 | 0.217 | Protein kinase C zeta inhibitor | 0.217 0.009 CID_14116 | CID_14116 | |
| 0.175 | 0.01 | 0.228 | Macrophage migration inhibitory factor inhibitor | 0.228 0.006 CID_14116 | CID_14116 | |
| 0.176 | 0.011 | 0.18 | Transcription factor STAT6 inhibitor | 0.18 0.01 CID_14116 | CID_14116 | |
| 0.168 | 0.004 | 0.168 | Granulocyte macrophage colony stimulating factor agonist | 0.163 0.004 CID_14116 | ||
| 0.169 | 0.006 | 0.169 | Glutamate release inhibitor | 0.147 0.01 CID_14116 | ||
| 0.203 | 0.041 | 0.203 | Cyclooxygenase inhibitor | 0.196 0.043 CID_14116 | ||
| 0.183 | 0.021 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.17 0.034 CID_14116 | ||
| 0.229 | 0.068 | 0.229 | Peptidyltransferase inhibitor | 0.213 0.083 CID_14116 | ||
| 0.216 | 0.056 | 0.239 | Hepatoprotectant | 0.239 0.046 CID_14116 | CID_14116 | |
| 0.191 | 0.031 | 0.203 | DNA polymerase I inhibitor | 0.203 0.027 CID_14116 | CID_14116 | |
| 0.174 | 0.014 | 0.174 | Phosphofructokinase-1 inhibitor | 0.141 0.02 CID_14116 | ||
| 0.175 | 0.016 | 0.175 | Sphingomyelinase inhibitor | 0.144 0.027 CID_14116 | ||
| 0.217 | 0.058 | 0.217 | I kappa B kinase epsilon inhibitor | 0.205 0.066 CID_14116 | ||
| 0.232 | 0.074 | 0.232 | Neuropeptide Y2 antagonist | 0.232 0.074 CID_14116 | ||
| 0.177 | 0.02 | 0.198 | Protein kinase C gamma inhibitor | 0.198 0.014 CID_14116 | CID_14116 | |
| 0.185 | 0.027 | 0.213 | MAO B inhibitor | 0.213 0.022 CID_14116 | CID_14116 | |
| 0.177 | 0.02 | 0.177 | Mucolytic | 0.171 0.022 CID_14116 | ||
| 0.161 | 0.005 | 0.272 | Estrogen receptor alpha agonist | 0.272 0.004 CID_14116 | CID_14116 | |
| 0.205 | 0.049 | 0.205 | 3C-like protease (Human coronavirus) inhibitor | 0.19 0.057 CID_14116 | ||
| 0.255 | 0.101 | 0.255 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.228 0.128 CID_14116 | ||
| 0.249 | 0.096 | 0.249 | Immunostimulant | 0.243 0.099 CID_14116 | ||
| 0.166 | 0.013 | 0.166 | Glutamate dehydrogenase inhibitor | 0.131 0.02 CID_14116 | ||
| 0.308 | 0.156 | 0.308 | Cyclophilin D inhibitor | 0.287 0.174 CID_14116 | ||
| 0.173 | 0.022 | 0.173 | Vanilloid 1 agonist | 0.166 0.026 CID_14116 | ||
| 0.189 | 0.037 | 0.189 | Hemostatic | 0.188 0.038 CID_14116 | ||
| 0.154 | 0.003 | 0.181 | Dopamine D5 agonist | 0.181 0.002 CID_14116 | CID_14116 | |
| 0.156 | 0.006 | 0.156 | Purinergic P2X1 antagonist | 0.131 0.009 CID_14116 | ||
| 0.232 | 0.082 | 0.232 | Calpain inhibitor | 0.221 0.094 CID_14116 | ||
| 0.169 | 0.021 | 0.188 | Papain-like protease (SARS coronavirus) inhibitor | 0.188 0.013 CID_14116 | CID_14116 | |
| 0.162 | 0.013 | 0.162 | CYP2A6 inhibitor | 0.144 0.018 CID_14116 | ||
| 0.232 | 0.084 | 0.265 | Tumour necrosis factor alpha release inhibitor | 0.265 0.068 CID_14116 | CID_14116 | |
| 0.153 | 0.005 | 0.176 | Topoisomerase II beta inhibitor | 0.176 0.004 CID_14116 | CID_14116 | |
| 0.194 | 0.046 | 0.197 | Phospholipase A2 inhibitor | 0.197 0.044 CID_14116 | CID_14116 | |
| 0.153 | 0.007 | 0.153 | GABA aminotransferase inhibitor | 0.147 0.008 CID_14116 | ||
| 0.159 | 0.014 | 0.165 | Anabolic | 0.165 0.011 CID_14116 | CID_14116 | |
| 0.165 | 0.019 | 0.165 | Uric acid excretion stimulant | 0.16 0.02 CID_14116 | ||
| 0.149 | 0.005 | 0.157 | Heat shock protein 90 beta antagonist | 0.157 0.004 CID_14116 | CID_14116 | |
| 0.166 | 0.022 | 0.166 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.027 CID_14116 | ||
| 0.146 | 0.006 | 0.158 | CD45 antagonist | 0.158 0.005 CID_14116 | CID_14116 | |
| 0.147 | 0.006 | 0.161 | NMDA receptor subunit 3B antagonist | 0.161 0.005 CID_14116 | CID_14116 | |
| 0.165 | 0.026 | 0.167 | Interleukin 8 antagonist | 0.167 0.025 CID_14116 | CID_14116 | |
| 0.143 | 0.005 | 0.143 | GABA B receptor agonist | 0.138 0.005 CID_14116 | ||
| 0.145 | 0.008 | 0.166 | Xanthine dehydrogenase inhibitor | 0.166 0.006 CID_14116 | CID_14116 | |
| 0.168 | 0.031 | 0.168 | Aminopeptidase B inhibitor | 0.154 0.036 CID_14116 | ||
| 0.142 | 0.005 | 0.15 | Estrogen-related receptor beta agonist | 0.15 0.004 CID_14116 | CID_14116 | |
| 0.166 | 0.029 | 0.166 | Expectorant | 0.16 0.031 CID_14116 | ||
| 0.145 | 0.009 | 0.145 | HIV-1 integrase inhibitor | 0.131 0.012 CID_14116 | ||
| 0.158 | 0.023 | 0.158 | Caspase 3 inhibitor | 0.142 0.034 CID_14116 | ||
| 0.204 | 0.073 | 0.204 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.203 0.074 CID_14116 | ||
| 0.165 | 0.036 | 0.165 | Antibacterial (Helicobacter pylori) | 0.154 0.043 CID_14116 | ||
| 0.132 | 0.003 | 0.192 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.192 0.003 CID_14116 | CID_14116 | |
| 0.133 | 0.005 | 0.139 | Fatty acid synthase inhibitor | 0.139 0.005 CID_14116 | CID_14116 | |
| 0.157 | 0.03 | 0.157 | Nav1.1 sodium channel blocker | 0.149 0.033 CID_14116 | ||
| 0.143 | 0.017 | 0.145 | Histamine N-methyltransferase inhibitor | 0.145 0.016 CID_14116 | CID_14116 | |
| 0.145 | 0.019 | 0.145 | Thioredoxin inhibitor | 0.145 0.018 CID_14116 | ||
| 0.145 | 0.021 | 0.145 | Electrolyte absorption antagonist | 0.12 0.036 CID_14116 | ||
| 0.14 | 0.016 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 CID_14116 | ||
| 0.148 | 0.024 | 0.187 | Breast cancer-resistant protein inhibitor | 0.187 0.015 CID_14116 | CID_14116 | |
| 0.127 | 0.005 | 0.127 | Aconitate hydratase inhibitor | 0.099 0.009 CID_14116 | ||
| 0.146 | 0.025 | 0.152 | Urease inhibitor | 0.152 0.022 CID_14116 | CID_14116 | |
| 0.19 | 0.068 | 0.192 | LIM domain kinase 1 inhibitor | 0.192 0.066 CID_14116 | CID_14116 | |
| 0.162 | 0.041 | 0.186 | Farnesoid X receptor antagonist | 0.186 0.026 CID_14116 | CID_14116 | |
| 0.131 | 0.01 | 0.131 | Glycine receptor agonist | 0.104 0.019 CID_14116 | ||
| 0.132 | 0.012 | 0.132 | Glycine receptor antagonist | 0.121 0.018 CID_14116 | ||
| 0.124 | 0.004 | 0.134 | MAP kinase kinase 7 inhibitor | 0.134 0.003 CID_14116 | CID_14116 | |
| 0.158 | 0.04 | 0.158 | Pregnane X receptor agonist | 0.157 0.041 CID_14116 | ||
| 0.158 | 0.04 | 0.158 | Cathepsin H inhibitor | 0.142 0.052 CID_14116 | ||
| 0.134 | 0.016 | 0.134 | Phosphodiesterase 6D inhibitor | 0.132 0.017 CID_14116 | ||
| 0.146 | 0.028 | 0.146 | CC chemokine 6 receptor antagonist | 0.13 0.069 CID_14116 | ||
| 0.129 | 0.011 | 0.131 | Carbonic anhydrase VB inhibitor | 0.131 0.011 CID_14116 | CID_14116 | |
| 0.141 | 0.023 | 0.141 | Acetylcholine release stimulant | 0.133 0.031 CID_14116 | ||
| 0.164 | 0.047 | 0.198 | Acetylcholinesterase inhibitor | 0.198 0.034 CID_14116 | CID_14116 | |
| 0.128 | 0.012 | 0.128 | Biliverdin reductase inhibitor | 0.096 0.02 CID_14116 | ||
| 0.137 | 0.022 | 0.137 | MAP kinase kinase 1 inhibitor | 0.125 0.031 CID_14116 | ||
| 0.131 | 0.015 | 0.133 | Myeloperoxidase inhibitor | 0.133 0.015 CID_14116 | CID_14116 | |
| 0.127 | 0.013 | 0.127 | T cell inhibitor | 0.112 0.017 CID_14116 | ||
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.103 0.02 CID_14116 | ||
| 0.16 | 0.047 | 0.16 | Cyclooxygenase 2 inhibitor | 0.156 0.05 CID_14116 | ||
| 0.152 | 0.039 | 0.152 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.056 CID_14116 | ||
| 0.122 | 0.011 | 0.122 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.097 0.015 CID_14116 | ||
| 0.162 | 0.051 | 0.162 | Nav1.2 sodium channel blocker | 0.142 0.062 CID_14116 | ||
| 0.13 | 0.019 | 0.133 | Carbonic anhydrase V inhibitor | 0.133 0.019 CID_14116 | CID_14116 | |
| 0.126 | 0.016 | 0.126 | ATPase (Vacuolar H+) inhibitor | 0.118 0.021 CID_14116 | ||
| 0.143 | 0.032 | 0.143 | Antineoplastic antibiotic | 0.137 0.034 CID_14116 | ||
| 0.117 | 0.007 | 0.127 | NMDA receptor subunit 3A antagonist | 0.127 0.006 CID_14116 | CID_14116 | |
| 0.115 | 0.005 | 0.115 | Glutamate (mGluR7) antagonist | 0.114 0.005 CID_14116 | ||
| 0.16 | 0.052 | 0.185 | Bone formation stimulant | 0.185 0.04 CID_14116 | CID_14116 | |
| 0.127 | 0.019 | 0.127 | Glutathione S-transferase inhibitor | 0.113 0.027 CID_14116 | ||
| 0.146 | 0.039 | 0.146 | Microtubule formation inhibitor | 0.136 0.046 CID_14116 | ||
| 0.117 | 0.011 | 0.117 | Maillard reaction inhibitor | 0.099 0.017 CID_14116 | ||
| 0.238 | 0.132 | 0.238 | Thyroid hormone antagonist | 0.218 0.146 CID_14116 | ||
| 0.127 | 0.021 | 0.127 | Ornithine decarboxylase inhibitor | 0.122 0.024 CID_14116 | ||
| 0.135 | 0.029 | 0.153 | NMDA receptor antagonist | 0.153 0.023 CID_14116 | CID_14116 | |
| 0.165 | 0.06 | 0.165 | Insulin secretagoues | 0.152 0.072 CID_14116 | ||
| 0.122 | 0.017 | 0.15 | Aromatase inhibitor | 0.15 0.013 CID_14116 | CID_14116 | |
| 0.144 | 0.039 | 0.144 | Falcipain 3 inhibitor | 0.122 0.052 CID_14116 | ||
| 0.163 | 0.058 | 0.163 | Thiol protease inhibitor | 0.146 0.073 CID_14116 | ||
| 0.113 | 0.009 | 0.113 | Phospholipase D inhibitor | 0.101 0.014 CID_14116 | ||
| 0.116 | 0.015 | 0.137 | Aldose reductase inhibitor | 0.137 0.012 CID_14116 | CID_14116 | |
| 0.158 | 0.056 | 0.158 | Cytokine production inhibitor | 0.155 0.058 CID_14116 | ||
| 0.13 | 0.029 | 0.143 | Androgen antagonist | 0.143 0.024 CID_14116 | CID_14116 | |
| 0.121 | 0.02 | 0.152 | Dopamine D1 antagonist | 0.152 0.015 CID_14116 | CID_14116 | |
| 0.119 | 0.018 | 0.122 | Carbonic anhydrase VA inhibitor | 0.122 0.017 CID_14116 | CID_14116 | |
| 0.129 | 0.029 | 0.129 | Interleukin 1 beta converting enzyme inhibitor | 0.12 0.035 CID_14116 | ||
| 0.112 | 0.012 | 0.124 | CC chemokine 5 receptor agonist | 0.124 0.007 CID_14116 | CID_14116 | |
| 0.164 | 0.066 | 0.164 | Cytidine deaminase inhibitor | 0.129 0.092 CID_14116 | ||
| 0.114 | 0.016 | 0.114 | Argininosuccinate synthase inhibitor | 0.083 0.024 CID_14116 | ||
| 0.117 | 0.02 | 0.117 | Aminopeptidase I inhibitor | 0.108 0.024 CID_14116 | ||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | 0.09 0.015 CID_14116 | ||
| 0.121 | 0.025 | 0.129 | Adrenaline agonist | 0.129 0.022 CID_14116 | CID_14116 | |
| 0.114 | 0.019 | 0.114 | Thioredoxin reductase inhibitor | 0.106 0.024 CID_14116 | ||
| 0.139 | 0.045 | 0.142 | Alpha 2b adrenoreceptor antagonist | 0.142 0.043 CID_14116 | CID_14116 | |
| 0.105 | 0.011 | 0.105 | Aryl hydrocarbon receptor antagonist | 0.101 0.013 CID_14116 | ||
| 0.151 | 0.057 | 0.151 | Interleukin 1 antagonist | 0.134 0.071 CID_14116 | ||
| 0.098 | 0.005 | 0.098 | Dihydroorotate oxidase inhibitor | 0.086 0.008 CID_14116 | ||
| 0.155 | 0.063 | 0.158 | Glycogen synthase kinase-3 alpha inhibitor | 0.158 0.061 CID_14116 | CID_14116 | |
| 0.115 | 0.024 | 0.119 | Bile acid receptor antagonist | 0.119 0.02 CID_14116 | CID_14116 | |
| 0.138 | 0.049 | 0.14 | Protein kinase (CK2) alpha inhibitor | 0.14 0.048 CID_14116 | CID_14116 | |
| 0.104 | 0.015 | 0.104 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 CID_14116 | ||
| 0.114 | 0.026 | 0.139 | NMDA 2 receptor antagonist | 0.139 0.019 CID_14116 | CID_14116 | |
| 0.159 | 0.071 | 0.159 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.082 CID_14116 | ||
| 0.1 | 0.013 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 CID_14116 | ||
| 0.101 | 0.014 | 0.106 | Beta 3 adrenoreceptor antagonist | 0.106 0.013 CID_14116 | CID_14116 | |
| 0.108 | 0.022 | 0.119 | Leukotriene synthesis inhibitor | 0.119 0.017 CID_14116 | CID_14116 | |
| 0.095 | 0.008 | 0.101 | Transcription factor RelA inhibitor | 0.101 0.006 CID_14116 | CID_14116 | |
| 0.157 | 0.071 | 0.157 | Diuretic | 0.155 0.073 CID_14116 | ||
| 0.108 | 0.022 | 0.108 | Sphingosine 1-phosphate receptor 4 agonist | 0.102 0.024 CID_14116 | ||
| 0.101 | 0.016 | 0.101 | Vanilloid 4 agonist | 0.088 0.029 CID_14116 | ||
| 0.222 | 0.137 | 0.222 | Thyroid hormone beta antagonist | 0.203 0.151 CID_14116 | ||
| 0.138 | 0.053 | 0.138 | Proteasome inhibitor | 0.133 0.056 CID_14116 | ||
| 0.125 | 0.041 | 0.125 | Electron transport complex I inhibitor | 0.114 0.056 CID_14116 | ||
| 0.098 | 0.014 | 0.108 | NMDA 2A receptor antagonist | 0.108 0.011 CID_14116 | CID_14116 | |
| 0.1 | 0.016 | 0.1 | NMDA receptor glycine site agonist | 0.081 0.028 CID_14116 | ||
| 0.163 | 0.08 | 0.168 | Antipruritic | 0.168 0.075 CID_14116 | CID_14116 | |
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | 0.079 0.007 CID_14116 | ||
| 0.09 | 0.008 | 0.09 | DNA helicase inhibitor | 0.078 0.012 CID_14116 | ||
| 0.087 | 0.005 | 0.087 | Adenylate cyclase 1 inhibitor | 0.078 0.009 CID_14116 | ||
| 0.098 | 0.017 | 0.106 | NMDA 2C receptor antagonist | 0.106 0.014 CID_14116 | CID_14116 | |
| 0.088 | 0.007 | 0.088 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 CID_14116 | ||
| 0.139 | 0.058 | 0.149 | MAP kinase kinase inhibitor | 0.149 0.052 CID_14116 | CID_14116 | |
| 0.107 | 0.026 | 0.107 | mTOR complex 2 inhibitor | 0.099 0.035 CID_14116 | ||
| 0.089 | 0.009 | 0.089 | Calcium channel P-type blocker | 0.081 0.014 CID_14116 | ||
| 0.087 | 0.008 | 0.09 | Squalene epoxidase inhibitor | 0.09 0.007 CID_14116 | CID_14116 | |
| 0.083 | 0.004 | 0.091 | ATP citrate lysase inhibitor | 0.091 0.004 CID_14116 | CID_14116 | |
| 0.084 | 0.005 | 0.084 | Alpha 1d adrenoreceptor agonist | 0.074 0.006 CID_14116 | ||
| 0.113 | 0.034 | 0.113 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 CID_14116 | ||
| 0.09 | 0.012 | 0.09 | Leukotriene B4 antagonist | 0.09 0.013 CID_14116 | ||
| 0.109 | 0.031 | 0.109 | Bromodomain-containing protein 2 inhibitor | 0.105 0.035 CID_14116 | ||
| 0.1 | 0.022 | 0.1 | Leukotriene antagonist | 0.096 0.023 CID_14116 | ||
| 0.09 | 0.012 | 0.09 | Plasminogen activator inhibitor antagonist | 0.083 0.014 CID_14116 | ||
| 0.088 | 0.011 | 0.088 | Heme oxygenase stimulant | 0.087 0.011 CID_14116 | ||
| 0.136 | 0.059 | 0.136 | Nav1.3 sodium channel blocker | 0.116 0.078 CID_14116 | ||
| 0.123 | 0.046 | 0.123 | Protein kinase (CK2) inhibitor | 0.122 0.047 CID_14116 | ||
| 0.083 | 0.007 | 0.083 | Retinoid X alpha receptor agonist | 0.067 0.01 CID_14116 | ||
| 0.088 | 0.012 | 0.088 | Sphingosine kinase 2 inhibitor | 0.085 0.013 CID_14116 | ||
| 0.095 | 0.019 | 0.099 | TRPA1 antagonist | 0.099 0.018 CID_14116 | CID_14116 | |
| 0.122 | 0.046 | 0.122 | Mediator release inhibitor | 0.121 0.046 CID_14116 | ||
| 0.104 | 0.028 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CID_14116 | ||
| 0.078 | 0.004 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.066 0.005 CID_14116 | ||
| 0.131 | 0.056 | 0.135 | Beta amyloid protein antagonist | 0.135 0.053 CID_14116 | CID_14116 | |
| 0.165 | 0.091 | 0.17 | Platelet adhesion inhibitor | 0.17 0.088 CID_14116 | CID_14116 | |
| 0.224 | 0.151 | 0.232 | Interleukin 2 agonist | 0.232 0.14 CID_14116 | CID_14116 | |
| 0.089 | 0.016 | 0.089 | Exportin-1 inhibitor | 0.087 0.018 CID_14116 | ||
| 0.086 | 0.013 | 0.086 | Sphingosine kinase inhibitor | 0.08 0.016 CID_14116 | ||
| 0.087 | 0.015 | 0.087 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.084 0.017 CID_14116 | ||
| 0.144 | 0.072 | 0.155 | Activin receptor-like kinase 2 inhibitor | 0.155 0.063 CID_14116 | CID_14116 | |
| 0.171 | 0.099 | 0.171 | Focal adhesion kinase 2 inhibitor | 0.157 0.119 CID_14116 | ||
| 0.12 | 0.049 | 0.127 | Alpha 2c adrenoreceptor antagonist | 0.127 0.045 CID_14116 | CID_14116 | |
| 0.13 | 0.06 | 0.13 | Anesthetic local | 0.104 0.079 CID_14116 | ||
| 0.091 | 0.02 | 0.093 | Beta adrenoreceptor antagonist | 0.093 0.02 CID_14116 | CID_14116 | |
| 0.098 | 0.028 | 0.101 | Lipase inhibitor | 0.101 0.026 CID_14116 | CID_14116 | |
| 0.078 | 0.008 | 0.078 | Retinoid X receptor agonist | 0.067 0.011 CID_14116 | ||
| 0.09 | 0.02 | 0.093 | Protein kinase C beta inhibitor | 0.093 0.017 CID_14116 | CID_14116 | |
| 0.155 | 0.085 | 0.167 | Cyclin-dependent kinase 3 inhibitor | 0.167 0.065 CID_14116 | CID_14116 | |
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 agonist | 0.09 0.02 CID_14116 | ||
| 0.079 | 0.009 | 0.084 | Ryanodine receptor antagonist | 0.084 0.007 CID_14116 | CID_14116 | |
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | 0.092 0.078 CID_14116 | ||
| 0.165 | 0.096 | 0.179 | P-glycoprotein inhibitor | 0.179 0.081 CID_14116 | CID_14116 | |
| 0.101 | 0.033 | 0.101 | Cathepsin G inhibitor | 0.09 0.038 CID_14116 | ||
| 0.084 | 0.016 | 0.084 | Dihydroorotate dehydrogenase inhibitor | 0.081 0.017 CID_14116 | ||
| 0.091 | 0.023 | 0.091 | NMDA receptor agonist | 0.071 0.035 CID_14116 | ||
| 0.073 | 0.006 | 0.073 | GABA uptake inhibitor | 0.058 0.011 CID_14116 | ||
| 0.077 | 0.011 | 0.077 | Lysophosphatidic acid 3 receptor antagonist | 0.069 0.015 CID_14116 | ||
| 0.095 | 0.029 | 0.107 | Dopamine agonist | 0.107 0.024 CID_14116 | CID_14116 | |
| 0.069 | 0.004 | 0.105 | Estrogen-related receptor beta antagonist | 0.105 0.003 CID_14116 | CID_14116 | |
| 0.134 | 0.069 | 0.134 | Sodium channel (voltage-gated) blocker | 0.128 0.075 CID_14116 | ||
| 0.108 | 0.042 | 0.108 | Calcium antagonist | 0.085 0.06 CID_14116 | ||
| 0.073 | 0.008 | 0.089 | Liver X receptor alpha agonist | 0.089 0.006 CID_14116 | CID_14116 | |
| 0.097 | 0.032 | 0.097 | Caspase 7 inhibitor | 0.087 0.047 CID_14116 | ||
| 0.094 | 0.03 | 0.094 | Prostaglandin-E synthase inhibitor | 0.084 0.036 CID_14116 | ||
| 0.071 | 0.007 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.069 0.009 CID_14116 | ||
| 0.081 | 0.017 | 0.081 | Cyclin D1 inhibitor | 0.076 0.022 CID_14116 | ||
| 0.15 | 0.087 | 0.15 | Growth hormone agonist | 0.133 0.103 CID_14116 | ||
| 0.072 | 0.009 | 0.078 | Purinergic P2X4 antagonist | 0.078 0.007 CID_14116 | CID_14116 | |
| 0.083 | 0.02 | 0.083 | I kappa B kinase 2 inhibitor | 0.075 0.026 CID_14116 | ||
| 0.156 | 0.093 | 0.167 | Death-associated protein kinase 2 inhibitor | 0.167 0.073 CID_14116 | CID_14116 | |
| 0.149 | 0.086 | 0.248 | Sigma receptor agonist | 0.248 0.049 CID_14116 | CID_14116 | |
| 0.072 | 0.01 | 0.073 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 CID_14116 | CID_14116 | |
| 0.07 | 0.008 | 0.07 | Geranyltranstransferase inhibitor | 0.06 0.014 CID_14116 | ||
| 0.084 | 0.022 | 0.092 | Androgen agonist | 0.092 0.018 CID_14116 | CID_14116 | |
| 0.075 | 0.013 | 0.076 | Beta 2 adrenoreceptor agonist | 0.076 0.012 CID_14116 | CID_14116 | |
| 0.084 | 0.022 | 0.084 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 CID_14116 | ||
| 0.142 | 0.08 | 0.142 | MAP kinase 3 inhibitor | 0.126 0.117 CID_14116 | ||
| 0.1 | 0.038 | 0.1 | I kappa B kinase inhibitor | 0.089 0.05 CID_14116 | ||
| 0.068 | 0.006 | 0.077 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.077 0.005 CID_14116 | CID_14116 | |
| 0.185 | 0.124 | 0.212 | MAP-kinase-activated kinase 5 inhibitor | 0.212 0.089 CID_14116 | CID_14116 | |
| 0.105 | 0.043 | 0.105 | Potassium channel activator | 0.082 0.072 CID_14116 | ||
| 0.112 | 0.052 | 0.128 | Toll-Like receptor 4 antagonist | 0.128 0.036 CID_14116 | CID_14116 | |
| 0.084 | 0.024 | 0.084 | Protease 3C (Human rhinovirus) inhibitor | 0.081 0.026 CID_14116 | ||
| 0.074 | 0.014 | 0.074 | Potassium channel Kv1.3 blocker | 0.06 0.021 CID_14116 | ||
| 0.094 | 0.034 | 0.094 | Interferon agonist | 0.083 0.048 CID_14116 | ||
| 0.078 | 0.018 | 0.078 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 CID_14116 | ||
| 0.071 | 0.012 | 0.071 | CXC chemokine 1 receptor antagonist | 0.065 0.017 CID_14116 | ||
| 0.121 | 0.062 | 0.121 | Interleukin 1b antagonist | 0.096 0.087 CID_14116 | ||
| 0.104 | 0.045 | 0.106 | ABCA1 expression enhancer | 0.106 0.043 CID_14116 | CID_14116 | |
| 0.09 | 0.03 | 0.099 | Amidase inhibitor | 0.099 0.025 CID_14116 | CID_14116 | |
| 0.083 | 0.024 | 0.088 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 CID_14116 | CID_14116 | |
| 0.07 | 0.011 | 0.07 | Dihydroorotase inhibitor | 0.064 0.014 CID_14116 | ||
| 0.118 | 0.059 | 0.118 | GABA receptor agonist | 0.102 0.075 CID_14116 | ||
| 0.105 | 0.046 | 0.121 | Interleukin 12 antagonist | 0.121 0.028 CID_14116 | CID_14116 | |
| 0.074 | 0.016 | 0.085 | Dopamine D2 agonist | 0.085 0.013 CID_14116 | CID_14116 | |
| 0.075 | 0.016 | 0.082 | 5 Hydroxytryptamine 7 agonist | 0.082 0.012 CID_14116 | CID_14116 | |
| 0.14 | 0.081 | 0.148 | Neuropeptide Y1 antagonist | 0.148 0.068 CID_14116 | CID_14116 | |
| 0.141 | 0.084 | 0.141 | Acetylcholine M1 receptor antagonist | 0.132 0.093 CID_14116 | ||
| 0.179 | 0.122 | 0.205 | Vasodilator | 0.205 0.101 CID_14116 | CID_14116 | |
| 0.065 | 0.008 | 0.065 | Guanylate cyclase inhibitor | 0.058 0.014 CID_14116 | ||
| 0.071 | 0.014 | 0.071 | Adenine nucleotide translocase inhibitor | 0.063 0.023 CID_14116 | ||
| 0.065 | 0.008 | 0.065 | DNA gyrase subunit A inhibitor | 0.059 0.011 CID_14116 | ||
| 0.076 | 0.02 | 0.076 | Beta 1 adrenoreceptor antagonist | 0.076 0.021 CID_14116 | ||
| 0.076 | 0.02 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.03 CID_14116 | ||
| 0.06 | 0.005 | 0.06 | Vanilloid 3 antagonist | 0.048 0.01 CID_14116 | ||
| 0.078 | 0.023 | 0.078 | MDM2 inhibitor | 0.069 0.04 CID_14116 | ||
| 0.067 | 0.012 | 0.067 | Cholesterol esterase inhibitor | 0.058 0.019 CID_14116 | ||
| 0.137 | 0.082 | 0.151 | MAP3K9 inhibitor | 0.151 0.059 CID_14116 | CID_14116 | |
| 0.088 | 0.034 | 0.094 | Cyclin B3 inhibitor | 0.094 0.031 CID_14116 | CID_14116 | |
| 0.115 | 0.061 | 0.115 | Nav1.5 sodium channel blocker | 0.107 0.073 CID_14116 | ||
| 0.07 | 0.016 | 0.073 | Beta 2 adrenoreceptor antagonist | 0.073 0.015 CID_14116 | CID_14116 | |
| 0.065 | 0.012 | 0.065 | Glutamate (mGluR4) antagonist | 0.048 0.023 CID_14116 | ||
| 0.059 | 0.006 | 0.068 | Liver X receptor beta antagonist | 0.068 0.005 CID_14116 | CID_14116 | |
| 0.059 | 0.007 | 0.061 | Catechol O-methyltransferase inhibitor | 0.061 0.006 CID_14116 | CID_14116 | |
| 0.064 | 0.011 | 0.064 | Glutamate (mGluR group III) antagonist | 0.052 0.019 CID_14116 | ||
| 0.084 | 0.031 | 0.084 | Acetylcholine M5 receptor agonist | 0.079 0.035 CID_14116 | ||
| 0.059 | 0.007 | 0.059 | Kainate receptor agonist | 0.051 0.013 CID_14116 | ||
| 0.07 | 0.018 | 0.07 | Lysine-specific demethylase 1A inhibitor | 0.07 0.018 CID_14116 | ||
| 0.069 | 0.017 | 0.069 | Alpha-mannosidase inhibitor | 0.061 0.025 CID_14116 | ||
| 0.06 | 0.009 | 0.06 | Nerve growth factor antagonist | 0.054 0.014 CID_14116 | ||
| 0.06 | 0.01 | 0.06 | Sirtuin 2 inhibitor | 0.041 0.017 CID_14116 | ||
| 0.062 | 0.011 | 0.062 | GABA B receptor antagonist | 0.058 0.013 CID_14116 | ||
| 0.055 | 0.005 | 0.055 | CF transmembrane conductance regulator antagonist | 0.05 0.009 CID_14116 | ||
| 0.071 | 0.021 | 0.071 | Glucosylceramidase inhibitor | 0.056 0.036 CID_14116 | ||
| 0.127 | 0.077 | 0.127 | Sodium channel blocker | 0.118 0.086 CID_14116 | ||
| 0.14 | 0.09 | 0.151 | Thrombolytic | 0.151 0.081 CID_14116 | CID_14116 | |
| 0.057 | 0.008 | 0.057 | Glutamate (mGluR8) agonist | 0.048 0.013 CID_14116 | ||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 CID_14116 | ||
| 0.061 | 0.013 | 0.061 | Urate transporter 1 inhibitor | 0.055 0.016 CID_14116 | ||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR3) antagonist | 0.047 0.015 CID_14116 | ||
| 0.064 | 0.017 | 0.064 | Heparanase inhibitor | 0.059 0.024 CID_14116 | ||
| 0.051 | 0.004 | 0.051 | Leukotriene B4 receptor 2 antagonist | 0.042 0.005 CID_14116 | ||
| 0.056 | 0.009 | 0.056 | Retinoid X receptor antagonist | 0.052 0.011 CID_14116 | ||
| 0.066 | 0.019 | 0.066 | Leukotriene C antagonist | 0.062 0.025 CID_14116 | ||
| 0.052 | 0.006 | 0.052 | Sodium/glucose cotransporter 2 inhibitor | 0.046 0.007 CID_14116 | ||
| 0.057 | 0.011 | 0.057 | Fumarate hydratase inhibitor | 0.044 0.016 CID_14116 | ||
| 0.05 | 0.004 | 0.055 | Thyroid hormone agonist | 0.055 0.004 CID_14116 | CID_14116 | |
| 0.066 | 0.021 | 0.066 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.034 CID_14116 | ||
| 0.104 | 0.059 | 0.126 | Bronchodilator | 0.126 0.041 CID_14116 | CID_14116 | |
| 0.053 | 0.008 | 0.053 | Free fatty acid receptor 1 antagonist | 0.042 0.014 CID_14116 | ||
| 0.239 | 0.194 | 0.239 | Transcription factor inhibitor | 0.215 0.213 CID_14116 | ||
| 0.09 | 0.046 | 0.092 | Vanilloid agonist | 0.092 0.044 CID_14116 | CID_14116 | |
| 0.073 | 0.029 | 0.073 | Carbonic anhydrase stimulant | 0.062 0.038 CID_14116 | ||
| 0.087 | 0.043 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | 0.078 0.052 CID_14116 | ||
| 0.056 | 0.012 | 0.062 | Nicotinic acid receptor agonist | 0.062 0.011 CID_14116 | CID_14116 | |
| 0.165 | 0.122 | 0.165 | Hypolipemic | 0.146 0.14 CID_14116 | ||
| 0.05 | 0.007 | 0.05 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 CID_14116 | ||
| 0.06 | 0.017 | 0.06 | Mannosidase inhibitor | 0.05 0.025 CID_14116 | ||
| 0.065 | 0.022 | 0.08 | Carbonic anhydrase XIV inhibitor | 0.08 0.016 CID_14116 | CID_14116 | |
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | 0.048 0.019 CID_14116 | ||
| 0.055 | 0.012 | 0.055 | Inosine monophosphate dehydrogenase inhibitor | 0.041 0.021 CID_14116 | ||
| 0.067 | 0.025 | 0.067 | Cannabinoid CB2 receptor antagonist | 0.058 0.031 CID_14116 | ||
| 0.05 | 0.009 | 0.05 | Lysophosphatidic acid 2 receptor antagonist | 0.036 0.015 CID_14116 | ||
| 0.049 | 0.008 | 0.051 | Protein kinase (CK2) beta inhibitor | 0.051 0.007 CID_14116 | CID_14116 | |
| 0.045 | 0.004 | 0.045 | Estrogen-related receptor gamma antagonist | 0.045 0.004 CID_14116 | ||
| 0.081 | 0.04 | 0.081 | Phosphodiesterase VI inhibitor | 0.081 0.04 CID_14116 | ||
| 0.123 | 0.083 | 0.138 | Toll-Like receptor 9 antagonist | 0.138 0.071 CID_14116 | CID_14116 | |
| 0.051 | 0.011 | 0.053 | Delayed rectifier potassium channel blocker | 0.053 0.01 CID_14116 | CID_14116 | |
| 0.072 | 0.032 | 0.072 | Interferon inducer | 0.061 0.05 CID_14116 | ||
| 0.089 | 0.049 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.081 0.061 CID_14116 | ||
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | 0.075 0.042 CID_14116 | ||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | 0.038 0.005 CID_14116 | ||
| 0.044 | 0.004 | 0.044 | Alpha 2a adrenoreceptor agonist | 0.033 0.005 CID_14116 | ||
| 0.051 | 0.012 | 0.051 | Heme oxygenase inhibitor | 0.049 0.014 CID_14116 | ||
| 0.056 | 0.017 | 0.056 | AICAR transformylase inhibitor | 0.051 0.021 CID_14116 | ||
| 0.047 | 0.009 | 0.047 | Uridine phosphorylase inhibitor | 0.033 0.015 CID_14116 | ||
| 0.046 | 0.01 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 CID_14116 | ||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.054 0.026 CID_14116 | ||
| 0.083 | 0.046 | 0.087 | Alpha 2a adrenoreceptor antagonist | 0.087 0.043 CID_14116 | CID_14116 | |
| 0.05 | 0.014 | 0.05 | Diamine oxidase inhibitor | 0.037 0.028 CID_14116 | ||
| 0.236 | 0.2 | 0.236 | DNA directed DNA polymerase inhibitor | 0.221 0.211 CID_14116 | ||
| 0.129 | 0.093 | 0.132 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.132 0.091 CID_14116 | CID_14116 | |
| 0.04 | 0.004 | 0.04 | Vanilloid 2 agonist | 0.034 0.006 CID_14116 | ||
| 0.057 | 0.022 | 0.061 | Oleamide hydrolase inhibitor | 0.061 0.02 CID_14116 | CID_14116 | |
| 0.105 | 0.07 | 0.123 | Multidrug resistance-associated protein 1 inhibitor | 0.123 0.045 CID_14116 | CID_14116 | |
| 0.037 | 0.003 | 0.037 | Antibiotic Anthracycline-like | 0.034 0.003 CID_14116 | ||
| 0.055 | 0.021 | 0.055 | Thymidylate synthase inhibitor | 0.049 0.029 CID_14116 | ||
| 0.055 | 0.021 | 0.055 | Oxytocin agonist | 0.055 0.021 CID_14116 | ||
| 0.049 | 0.015 | 0.049 | Retinoic acid alpha receptor agonist | 0.041 0.024 CID_14116 | ||
| 0.107 | 0.074 | 0.107 | 5 Hydroxytryptamine 2B antagonist | 0.1 0.084 CID_14116 | ||
| 0.04 | 0.007 | 0.04 | Sodium/glucose cotransporter inhibitor | 0.038 0.007 CID_14116 | ||
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | 0.046 0.044 CID_14116 | ||
| 0.064 | 0.032 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | 0.064 0.033 CID_14116 | ||
| 0.134 | 0.101 | 0.14 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.14 0.096 CID_14116 | CID_14116 | |
| 0.062 | 0.03 | 0.062 | Ornithine carbamoyltransferase inhibitor | 0.048 0.041 CID_14116 | ||
| 0.041 | 0.009 | 0.041 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_14116 | ||
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 2 agonist | 0.058 0.029 CID_14116 | ||
| 0.084 | 0.053 | 0.122 | Opioid kappa receptor antagonist | 0.122 0.023 CID_14116 | CID_14116 | |
| 0.05 | 0.018 | 0.051 | Beta adrenoreceptor agonist | 0.051 0.016 CID_14116 | CID_14116 | |
| 0.053 | 0.022 | 0.056 | Fructose-1,6-bisphosphatase inhibitor | 0.056 0.02 CID_14116 | CID_14116 | |
| 0.233 | 0.202 | 0.233 | DNA polymerase beta inhibitor | 0.218 0.211 CID_14116 | ||
| 0.085 | 0.054 | 0.085 | GABA A receptor agonist | 0.076 0.071 CID_14116 | ||
| 0.073 | 0.043 | 0.076 | Alpha adrenoreceptor agonist | 0.076 0.041 CID_14116 | CID_14116 | |
| 0.044 | 0.013 | 0.044 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CID_14116 | ||
| 0.046 | 0.016 | 0.046 | Phosphoglycerate kinase inhibitor | 0.04 0.02 CID_14116 | ||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.044 0.043 CID_14116 | ||
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | 0.061 0.046 CID_14116 | ||
| 0.043 | 0.013 | 0.051 | Liver X receptor beta agonist | 0.051 0.01 CID_14116 | CID_14116 | |
| 0.054 | 0.024 | 0.062 | Carbonic anhydrase VII inhibitor | 0.062 0.018 CID_14116 | CID_14116 | |
| 0.034 | 0.004 | 0.036 | Nicotinic acid receptor 1 antagonist | 0.036 0.004 CID_14116 | CID_14116 | |
| 0.059 | 0.03 | 0.059 | Epithelial sodium channel blocker | 0.056 0.035 CID_14116 | ||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | 0.033 0.005 CID_14116 | ||
| 0.057 | 0.027 | 0.057 | Vanilloid 2 antagonist | 0.052 0.036 CID_14116 | ||
| 0.048 | 0.019 | 0.052 | Progesterone antagonist | 0.052 0.017 CID_14116 | CID_14116 | |
| 0.039 | 0.01 | 0.045 | Liver X receptor alpha antagonist | 0.045 0.007 CID_14116 | CID_14116 | |
| 0.042 | 0.013 | 0.042 | Retinoid X alpha receptor antagonist | 0.038 0.017 CID_14116 | ||
| 0.047 | 0.019 | 0.047 | Dihydropteroate synthase inhibitor | 0.043 0.023 CID_14116 | ||
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | 0.03 0.009 CID_14116 | ||
| 0.062 | 0.034 | 0.062 | Bcl-xL inhibitor | 0.06 0.039 CID_14116 | ||
| 0.065 | 0.037 | 0.065 | 5 Hydroxytryptamine 5A antagonist | 0.064 0.038 CID_14116 | ||
| 0.073 | 0.045 | 0.073 | Secretase beta inhibitor | 0.071 0.048 CID_14116 | ||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | 0.032 0.014 CID_14116 | ||
| 0.048 | 0.021 | 0.048 | Thymidine kinase inhibitor | 0.04 0.029 CID_14116 | ||
| 0.032 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | 0.03 0.005 CID_14116 | ||
| 0.06 | 0.033 | 0.06 | Bombesin 3 receptor antagonist | |||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | 0.053 0.04 CID_14116 | ||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_14116 | ||
| 0.045 | 0.019 | 0.047 | Arginase inhibitor | 0.047 0.017 CID_14116 | CID_14116 | |
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | 0.046 0.042 CID_14116 | ||
| 0.035 | 0.01 | 0.035 | CXC chemokine 2 receptor antagonist | 0.026 0.018 CID_14116 | ||
| 0.039 | 0.014 | 0.039 | Glucagon receptor antagonist | 0.033 0.018 CID_14116 | ||
| 0.094 | 0.07 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.053 | 0.029 | 0.053 | AMPA receptor antagonist | 0.046 0.035 CID_14116 | ||
| 0.094 | 0.07 | 0.094 | Cyclin-dependent kinase 9 inhibitor | 0.088 0.079 CID_14116 | ||
| 0.044 | 0.02 | 0.044 | TRPM8 blocker | |||
| 0.047 | 0.023 | 0.047 | CDK5/p25 inhibitor | 0.045 0.025 CID_14116 | ||
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 CID_14116 | ||
| 0.038 | 0.015 | 0.045 | Liver X receptor antagonist | 0.045 0.011 CID_14116 | CID_14116 | |
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.03 CID_14116 | ||
| 0.038 | 0.015 | 0.038 | Cholesterol ester transfer protein antagonist | 0.032 0.021 CID_14116 | ||
| 0.074 | 0.052 | 0.074 | Adenosine A3 receptor antagonist | |||
| 0.069 | 0.046 | 0.069 | Sirtuin 1 inhibitor | 0.064 0.053 CID_14116 | ||
| 0.027 | 0.005 | 0.035 | NMDA receptor phencyclidine site antagonist | 0.035 0.004 CID_14116 | CID_14116 | |
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | 0.039 0.027 CID_14116 | ||
| 0.027 | 0.005 | 0.027 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 CID_14116 | ||
| 0.03 | 0.009 | 0.033 | Dopamine D1 agonist | 0.033 0.008 CID_14116 | CID_14116 | |
| 0.044 | 0.023 | 0.044 | Acid-sensing ion channel blocker | 0.044 0.023 CID_14116 | ||
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | 0.037 0.032 CID_14116 | ||
| 0.084 | 0.064 | 0.086 | Interleukin 5 antagonist | 0.086 0.06 CID_14116 | CID_14116 | |
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_14116 | ||
| 0.076 | 0.056 | 0.076 | Metalloproteinase-2 inhibitor | 0.07 0.065 CID_14116 | ||
| 0.036 | 0.016 | 0.036 | Prostaglandin agonist | 0.03 0.022 CID_14116 | ||
| 0.059 | 0.039 | 0.059 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 CID_14116 | ||
| 0.025 | 0.005 | 0.025 | Estrogen-related receptor gamma agonist | 0.025 0.005 CID_14116 | ||
| 0.09 | 0.07 | 0.111 | Butyrylcholinesterase inhibitor | 0.111 0.053 CID_14116 | CID_14116 | |
| 0.024 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.02 0.007 CID_14116 | ||
| 0.056 | 0.036 | 0.056 | Thromboxane antagonist | |||
| 0.048 | 0.028 | 0.048 | Purinergic P2Y antagonist | |||
| 0.044 | 0.026 | 0.044 | Angiotensin AT1 receptor antagonist | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_14116 | ||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | 0.085 0.068 CID_14116 | ||
| 0.11 | 0.091 | 0.182 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.182 0.047 CID_14116 | CID_14116 | |
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.022 | 0.004 | 0.022 | Antibiotic Tetracycline-like | 0.019 0.005 CID_14116 | ||
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | 0.035 0.019 CID_14116 | ||
| 0.03 | 0.013 | 0.037 | Dopamine autoreceptor agonist | 0.037 0.01 CID_14116 | CID_14116 | |
| 0.04 | 0.022 | 0.04 | Kainate receptor 2 antagonist | |||
| 0.031 | 0.014 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.027 0.02 CID_14116 | ||
| 0.08 | 0.063 | 0.097 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.097 0.041 CID_14116 | CID_14116 | |
| 0.081 | 0.064 | 0.083 | Alpha 2 adrenoreceptor antagonist | 0.083 0.062 CID_14116 | CID_14116 | |
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | 0.026 0.019 CID_14116 | ||
| 0.037 | 0.021 | 0.037 | RNA-directed RNA polymerase inhibitor | 0.032 0.027 CID_14116 | ||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | |||
| 0.033 | 0.017 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.017 CID_14116 | ||
| 0.026 | 0.01 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 CID_14116 | ||
| 0.024 | 0.008 | 0.024 | Retinoid X beta receptor antagonist | 0.022 0.011 CID_14116 | ||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | |||
| 0.021 | 0.006 | 0.021 | Telomerase stimulant | 0.019 0.009 CID_14116 | ||
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | 0.067 0.063 CID_14116 | ||
| 0.048 | 0.033 | 0.048 | Aldosterone antagonist | 0.045 0.037 CID_14116 | ||
| 0.185 | 0.171 | 0.185 | MAP kinase kinase 3 inhibitor | |||
| 0.02 | 0.005 | 0.02 | Egl nine homolog 1 inhibitor | 0.018 0.007 CID_14116 | ||
| 0.06 | 0.045 | 0.06 | Cannabinoid CB1 receptor antagonist | |||
| 0.091 | 0.077 | 0.091 | Gastric antisecretory | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.007 CID_14116 | ||
| 0.04 | 0.026 | 0.04 | VCAM-1 antagonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.022 CID_14116 | ||
| 0.049 | 0.035 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.058 | 0.044 | 0.058 | Acetylcholine M3 receptor antagonist | 0.054 0.048 CID_14116 | ||
| 0.062 | 0.048 | 0.062 | Neutrophil collagenase inhibitor | |||
| 0.04 | 0.026 | 0.04 | VCAM antagonist | |||
| 0.112 | 0.098 | 0.117 | Toll-Like receptor antagonist | 0.117 0.089 CID_14116 | CID_14116 | |
| 0.031 | 0.017 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.025 0.013 CID_14116 | ||
| 0.024 | 0.011 | 0.024 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.058 | 0.045 | 0.058 | Phosphodiesterase 1B inhibitor | |||
| 0.06 | 0.048 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.059 0.051 CID_14116 | ||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | 0.019 0.016 CID_14116 | ||
| 0.041 | 0.028 | 0.041 | Kainate receptor antagonist | |||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.039 | 0.027 | 0.039 | 5 Hydroxytryptamine 2B agonist | 0.037 0.031 CID_14116 | ||
| 0.028 | 0.015 | 0.028 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.04 | 0.028 | 0.04 | Erythropoietin receptor agonist | 0.037 0.031 CID_14116 | ||
| 0.034 | 0.022 | 0.046 | Melatonin 2 agonist | 0.046 0.012 CID_14116 | CID_14116 | |
| 0.037 | 0.026 | 0.037 | Integrin alpha2 antagonist | |||
| 0.026 | 0.015 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | 0.031 0.022 CID_14116 | ||
| 0.121 | 0.11 | 0.121 | Death-associated protein kinase 1 inhibitor | |||
| 0.08 | 0.069 | 0.128 | Opioid antagonist | 0.128 0.033 CID_14116 | CID_14116 | |
| 0.049 | 0.038 | 0.049 | Prolyl endopeptidase inhibitor | |||
| 0.047 | 0.037 | 0.047 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_14116 | ||
| 0.054 | 0.044 | 0.054 | Adenosine A1 receptor antagonist | |||
| 0.014 | 0.004 | 0.016 | Thyroid hormone beta agonist | 0.016 0.004 CID_14116 | CID_14116 | |
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | 0.013 0.007 CID_14116 | ||
| 0.022 | 0.012 | 0.029 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.029 0.01 CID_14116 | CID_14116 | |
| 0.19 | 0.181 | 0.19 | Thioredoxin glutathione reductase inhibitor | |||
| 0.025 | 0.016 | 0.025 | Glutamate (mGluR1) agonist | 0.023 0.022 CID_14116 | ||
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.021 0.016 CID_14116 | ||
| 0.049 | 0.04 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.035 CID_14116 | CID_14116 | |
| 0.037 | 0.028 | 0.037 | Farnesoid X receptor agonist | |||
| 0.057 | 0.048 | 0.116 | Opioid delta receptor antagonist | 0.116 0.027 CID_14116 | CID_14116 | |
| 0.051 | 0.042 | 0.051 | GABA receptor antagonist | 0.048 0.047 CID_14116 | ||
| 0.038 | 0.029 | 0.042 | Dopamine D3 agonist | 0.042 0.025 CID_14116 | CID_14116 | |
| 0.033 | 0.025 | 0.033 | Angiotensin II receptor antagonist | |||
| 0.053 | 0.045 | 0.053 | Plasminogen activator inhibitor | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin E2 agonist | |||
| 0.026 | 0.018 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.053 | 0.045 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 CID_14116 | ||
| 0.023 | 0.015 | 0.026 | Beta 1 adrenoreceptor agonist | 0.026 0.011 CID_14116 | CID_14116 | |
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.032 | 0.024 | 0.051 | Estrogen-related receptor alpha antagonist | 0.051 0.013 CID_14116 | CID_14116 | |
| 0.038 | 0.03 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | |||
| 0.019 | 0.012 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 CID_14116 | ||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_14116 | ||
| 0.023 | 0.016 | 0.023 | Prostaglandin EP2 agonist | |||
| 0.056 | 0.049 | 0.056 | Acetylcholine M5 receptor antagonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | |||
| 0.071 | 0.064 | 0.08 | Somatostatin 1 agonist | 0.08 0.051 CID_14116 | CID_14116 | |
| 0.11 | 0.104 | 0.11 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 CID_14116 | ||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.042 | 0.035 | 0.042 | Phosphorylase inhibitor | |||
| 0.072 | 0.065 | 0.072 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.066 CID_14116 | ||
| 0.024 | 0.018 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.026 | 0.02 | 0.026 | Calcium-sensing receptor agonist | |||
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | 0.009 0.007 CID_14116 | ||
| 0.023 | 0.018 | 0.023 | Protein 30S ribosomal subunit inhibitor | |||
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.026 | 0.021 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 CID_14116 | CID_14116 | |
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.018 | 0.013 | 0.018 | Retinoic acid receptor antagonist | |||
| 0.042 | 0.037 | 0.05 | Glycine transporter 2 inhibitor | 0.05 0.03 CID_14116 | CID_14116 | |
| 0.135 | 0.13 | 0.163 | Lipocortins synthesis antagonist | 0.163 0.088 CID_14116 | CID_14116 | |
| 0.017 | 0.012 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_14116 | CID_14116 | |
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.015 | 0.01 | 0.015 | Calcium-sensing receptor antagonist | 0.014 0.012 CID_14116 | ||
| 0.008 | 0.004 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.022 | 0.017 | 0.022 | Retinoic acid gamma receptor agonist | |||
| 0.041 | 0.037 | 0.041 | Histamine H1 receptor agonist | |||
| 0.059 | 0.056 | 0.061 | Prolactin release inhibitor | 0.061 0.048 CID_14116 | CID_14116 | |
| 0.048 | 0.044 | 0.048 | GABA A receptor antagonist | |||
| 0.016 | 0.013 | 0.016 | G-protein-coupled receptor 120 agonist | |||
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | |||
| 0.116 | 0.113 | 0.139 | Cholinergic | 0.139 0.087 CID_14116 | CID_14116 | |
| 0.019 | 0.016 | 0.019 | Retinoic acid beta receptor agonist | |||
| 0.041 | 0.038 | 0.041 | Dihydrofolate reductase inhibitor | |||
| 0.029 | 0.027 | 0.029 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.048 | 0.046 | 0.07 | Protein kinase C eta inhibitor | 0.07 0.029 CID_14116 | CID_14116 | |
| 0.136 | 0.133 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.148 0.122 CID_14116 | CID_14116 | |
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.035 | 0.033 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.032 CID_14116 | ||
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.055 | 0.054 | 0.055 | Phosphodiesterase 1A inhibitor | |||
| 0.061 | 0.06 | 0.061 | Cannabinoid receptor antagonist | |||
| 0.046 | 0.045 | 0.051 | Factor III inhibitor | 0.051 0.032 CID_14116 | CID_14116 | |
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.005 | 0.005 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 CID_14116 | CID_14116 | |
| 0.243 | 0.242 | 0.243 | MAP kinase 1 inhibitor | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.035 | 0.034 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.038 | 0.04 | 0.043 | Liver X receptor agonist | 0.043 0.031 CID_14116 | CID_14116 | |
| 0.056 | 0.059 | 0.109 | Opioid mu receptor antagonist | 0.109 0.028 CID_14116 | CID_14116 | |
| 0.057 | 0.061 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.056 CID_14116 | CID_14116 | |
| 0.062 | 0.066 | 0.092 | Histone deacetylase stimulant | 0.092 0.034 CID_14116 | CID_14116 | |
| 0.062 | 0.066 | 0.092 | Histone deacetylase SIRT1 stimulant | 0.092 0.034 CID_14116 | CID_14116 | |
| 0.019 | 0.023 | 0.023 | CYP24 inhibitor | 0.023 0.016 CID_14116 | CID_14116 | |
| 0.034 | 0.038 | 0.051 | Dopamine D5 antagonist | 0.051 0.025 CID_14116 | CID_14116 | |
| 0.046 | 0.052 | 0.077 | NMDA 2B receptor antagonist | 0.077 0.022 CID_14116 | CID_14116 | |
| 0.051 | 0.059 | 0.059 | Purinergic P2X2 antagonist | 0.059 0.052 CID_14116 | CID_14116 | |
| 0.064 | 0.072 | 0.098 | Analgesic, opioid | 0.098 0.032 CID_14116 | CID_14116 | |
| 0.016 | 0.024 | 0.023 | Estrone sulfatase inhibitor | 0.023 0.014 CID_14116 | CID_14116 | |
| 0.108 | 0.122 | 0.144 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.144 0.079 CID_14116 | CID_14116 | |
| 0.086 | 0.102 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.09 CID_14116 | CID_14116 | |
| 0.027 | 0.043 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.028 CID_14116 | CID_14116 | |
| 0.027 | 0.044 | 0.037 | Opioid delta receptor agonist | 0.037 0.022 CID_14116 | CID_14116 | |
| 0.066 | 0.089 | 0.079 | Antineoplastic alkaloid | 0.079 0.066 CID_14116 | CID_14116 | |
| 0.049 | 0.073 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 CID_14116 | CID_14116 | |
| 0.032 | 0.059 | 0.051 | Opioid mu receptor agonist | 0.051 0.028 CID_14116 | CID_14116 | |
| 0.061 | 0.088 | 0.074 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.074 0.06 CID_14116 | CID_14116 | |
| 0.123 | 0.157 | 0.168 | Antimitotic | 0.168 0.105 CID_14116 | CID_14116 | |
| 0.019 | 0.068 | 0.035 | Kinesin-like protein 1 inhibitor | 0.035 0.028 CID_14116 | CID_14116 | |
| 0.019 | 0.068 | 0.035 | Kinesin antagonist | 0.035 0.028 CID_14116 | CID_14116 | |
| 0.044 | 0.096 | 0.065 | Check point kinase 1 inhibitor | 0.065 0.05 CID_14116 | CID_14116 | |
| 0.026 | 0.082 | 0.051 | Opioid agonist | 0.051 0.039 CID_14116 | CID_14116 | |
| 0.047 | 0.105 | 0.069 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.069 0.061 CID_14116 | CID_14116 | |
| 0.069 | 0.129 | 0.105 | c-Src kinase inhibitor | 0.105 0.086 CID_14116 | CID_14116 | |
| 0.037 | 0.123 | 0.063 | Phosphodiesterase 4D inhibitor | 0.063 0.062 CID_14116 | CID_14116 | |
| 0.132 | 0.244 | 0.174 | ErbB-1 antagonist | 0.174 0.126 CID_14116 | CID_14116 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |